| Long-term outcomes of colectomy surgery among patients with ulcerative colitis C Brown, PR Gibson, A Hart, GG Kaplan, S Kachroo, Q Ding, ... Springerplus 4, 1-11, 2015 | 54 | 2015 |
| Economic burden, mortality, and institutionalization in patients newly diagnosed with Alzheimer’s disease CM Black, H Fillit, L Xie, X Hu, MF Kariburyo, BM Ambegaonkar, O Baser, ... Journal of Alzheimer's Disease 61 (1), 185-193, 2018 | 47 | 2018 |
| Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis J Sieper, X Hu, CM Black, K Grootscholten, RWM van den Broek, ... Seminars in Arthritis and Rheumatism 46 (6), 746-753, 2017 | 47 | 2017 |
| Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices V Velcheti, X Hu, B Piperdi, T Burke Scientific reports 11 (1), 9222, 2021 | 45 | 2021 |
| First-line pembrolizumab in PD-L1 positive non-small-cell lung cancer: A cost-effectiveness analysis from the UK health care perspective X Hu, JW Hay Lung Cancer 123, 166-171, 2018 | 45 | 2018 |
| Pembrolizumab plus chemotherapy for Chinese patients with metastatic squamous NSCLC in KEYNOTE-407 Y Cheng, L Zhang, J Hu, D Wang, CP Hu, J Zhou, L Wu, L Cao, J Liu, ... JTO Clinical and Research Reports 2 (10), 100225, 2021 | 36 | 2021 |
| Non-professional caregiver burden is associated with the severity of patients’ cognitive impairment CM Black, CW Ritchie, RK Khandker, R Wood, E Jones, X Hu, ... PloS one 13 (12), e0204110, 2018 | 36 | 2018 |
| Cost utility analysis of urethral bulking agents versus midurethral sling in stress urinary incontinence CM Kunkle, JL Hallock, X Hu, J Blomquist, SF Thung, EF Werner Urogynecology 21 (3), 154-159, 2015 | 35 | 2015 |
| Burden of illness associated with non-radiographic axial spondyloarthritis: a multiperspective European cross-sectional observational study J Sieper, T Holbrook, CM Black, R Wood, X Hu, S Kachroo Clin Exp Rheumatol 34 (6), 975-983, 2016 | 26 | 2016 |
| Long-Term Real-World Outcomes of First-Line Pembrolizumab Monotherapy for Metastatic Non-Small Cell Lung Cancer With ≥50% Expression of Programmed Cell Death-Ligand 1 V Velcheti, X Hu, L Yang, MC Pietanza, T Burke Frontiers in Oncology 12, 834761, 2022 | 20 | 2022 |
| Pembrolizumab-combination therapy for previously untreated metastatic nonsquamous NSCLC: real-world outcomes at US oncology practices SV Liu, X Hu, Y Li, B Zhao, T Burke, V Velcheti Frontiers in Oncology 12, 999343, 2022 | 13 | 2022 |
| Treatment patterns and outcomes in resected early-stage non-small cell lung cancer: an analysis of the SEER-Medicare data H West, X Hu, S Zhang, Y Song, D Chirovsky, C Gao, A Lerner, A Jiang, ... Clinical Lung Cancer 24 (3), 260-268, 2023 | 12 | 2023 |
| Real-world time on treatment with first-line pembrolizumab monotherapy for advanced NSCLC with PD-L1 expression≥ 50%: 3-year follow-up data V Velcheti, X Hu, Y Li, H El-Osta, MC Pietanza, T Burke Cancers 14 (4), 1041, 2022 | 12 | 2022 |
| Trends in the price per median and mean life-year gained among newly approved cancer therapies 1995 to 2017 AJ Chen, X Hu, RM Conti, AB Jena, DP Goldman Value in Health 22 (12), 1387-1395, 2019 | 8 | 2019 |
| Quantifying the diagnostic pathway for patients with cognitive impairment: real-world data from seven European and North American countries CW Ritchie, CM Black, RK Khandker, R Wood, E Jones, X Hu, ... Journal of Alzheimer's Disease 62 (1), 457-466, 2018 | 8 | 2018 |
| Multi-national, cross-sectional survey of healthcare resource utilization in patients with all stages of cognitive impairment, analyzed by disease severity, country, and … RK Khandker, CW Ritchie, CM Black, R Wood, E Jones, X Hu, ... Journal of Alzheimer's Disease 75 (4), 1141-1152, 2020 | 7 | 2020 |
| First-line pembrolizumab plus chemotherapy for advanced squamous NSCLC: Real-world outcomes at US Oncology practices SV Liu, P Rai, D Wang, X Hu, PO Schwarzenberger JTO Clinical and Research Reports 4 (2), 100444, 2023 | 5 | 2023 |
| 1328P Clinical outcomes of pembrolizumab plus chemotherapy in non-squamous metastatic NSCLC patients aged 75 years or older at US oncology practices V Velcheti, X Hu, X Chen, B Piperdi, T Burke Annals of Oncology 31, S856, 2020 | 5 | 2020 |
| Quality of life of patients with Alzheimer's disease-A comparison with general population R Wood, E Jones, X Hu, RK Khandker, BM Ambegaonkar, CM Black Value in Health 19 (7), A436, 2016 | 5 | 2016 |
| Event-free survival as a predictor of overall survival and recurrence burden of patients with non–small cell lung cancer receiving neoadjuvant therapy J Donington, X Hu, S Zhang, Y Song, A Arunachalam, D Chirovsky, C Gao, ... The Journal of Thoracic and Cardiovascular Surgery, 2023 | 3 | 2023 |
